Contact

Our portfolio

PsyPhy

PsyPhy offers the PsyPhy Mobile Lab (PML), a comprehensive solution for recording neural activity and conducting behavioral research. The PML includes hardware, software, and subscription-based support for data analysis and education. PsyPhy aims to revolutionize neurophysiological education with accessible, high-quality equipment. The company addresses emerging markets for portable EEG and GSR devices.

  • Institute: University of Amsterdam
Industry: Diagnostics, Electronics, Medical Technology
  • Founding year: 2023
Visit website

Want to get in contact about PsyPhy?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

DCPrime
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.
Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Deep Sleep Technologies
Enhancing deep sleep through real-time, non-invasive brainwave stimulation using adaptive, science-backed algorithms.
DCPrime
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.
Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Deep Sleep Technologies
Enhancing deep sleep through real-time, non-invasive brainwave stimulation using adaptive, science-backed algorithms.
Explore full AAV portfolio
Contact